A process of converting a carbon-carbon double bond on a substrate into a cyclopropane ring, which method comprises the step of treating the substrate with a N-alkyl-N-nitroso compound, a transition metal catalyst and an aqueous base, wherein the N-alkyl-N-nitroso compound is formed by reacting an alkyl amine with an alkali metal nitrite in the presence of a mono-basic or di-basic acid, or a mixture thereof, and wherein the N-alkyl-N-nitroso compound is not distilled before it is mixed with the substrate, catalyst and base.

An electrophoretic medium that may be incorporated into an electrophoretic display includes a dispersion that may be contained in a plurality of microcapsules or microcells or a polymeric continuous phase. The dispersion may include a non-polar fluid, a plurality of first charged particles; and an inhibitor of photo-thermally induced polymerization that inhibits potential cross-linking between the particles and/or the microcells or polymeric continuous phase. The inhibitor may be a compound having an unsaturated hydrocarbon ring and at least one of a hydroxyl group, a carbonyl group, and a nitroso group. The plurality of microcells or polymeric continuous phase and a coating of the particles may include a polymeric material that includes (meth)acrylates.

An electrophoretic medium that may be incorporated into an electrophoretic display includes a dispersion that may be contained in a plurality of microcapsules or microcells or a polymeric continuous phase. The dispersion may include a non-polar fluid, a plurality of first charged particles; and an inhibitor of photo-thermally induced polymerization that inhibits potential cross-linking between the particles and/or the microcells or polymeric continuous phase. The inhibitor may be a compound having an unsaturated hydrocarbon ring and at least one of a hydroxyl group, a carbonyl group, and a nitroso group. The plurality of microcells or polymeric continuous phase and a coating of the particles may include a polymeric material that includes (meth)acrylates.

Disclosed is NO donor compound and preparation method, pharmaceutical composition, and use. The compound has a structure represented by formula The NO donor compound and the pharmaceutical composition thereof, as hypoxia-activated NO donors, may be prepared as drugs for treating myocardial hypoxic damage disease. The prepared drugs can exert efficacy at both the cellular level and the animal level, and the synthesis method of the compound is simple and easy to operate.

##STR00001##

Provided are compounds that can find use as nitrosation reagents. Provided are nitrosation methods that include reacting a substrate with one of the provided nitrosation reagents and thereby generating a nitrosation product. Provided are kits including a nitrosation reagent. Provided are compositions wherein the nitrosation reagent is enriched in the .sup.15N isotope.